Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy
about
sameAs
Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle releaseSyndecan-1 and Its Expanding List of ContactsVentilatory chemosensory drive is blunted in the mdx mouse model of Duchenne Muscular Dystrophy (DMD).Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in ratsDecorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activityACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.Cell-matrix interactions in muscle disease.Role of proteoglycans in the regulation of the skeletal muscle fibrotic response.Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers.Syndecans in skeletal muscle development, regeneration and homeostasis.Renin-angiotensin system: an old player with novel functions in skeletal muscle.Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent signaling, and inhibits TGF-β-dependent fibrotic response in skeletal muscAndrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis.Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-beta and CTGF/CCN2.Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis.Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease.Normal labor associated with changes in uterine heparan sulfate proteoglycan expression and localization.Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy.Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
P2860
Q24296220-346B6795-B1E4-4BE7-B45F-CC6571D54978Q28084514-A368677B-2500-4FE6-8AB9-B097E8649F8FQ34903075-0FFA64F4-4F83-48CF-A28F-5D6450F66EF7Q34999815-7271D9D2-388C-4BE4-A2E6-406ECD24E3E1Q35085132-4CA43561-A2E4-41D6-9186-687697660C26Q35138448-7958FEBC-22DF-48A7-BB8A-85AFFF768108Q37566483-2CD03A0B-78E2-451B-B446-F0D979A7ECB0Q37944530-E4385932-9202-45E2-87AE-EB40F2EA1C90Q38096495-0220C1A3-52F6-4450-A1F4-BA12322E70FCQ38103213-B2FBF7B7-6399-421D-9127-F86A8D0BE043Q38112137-0E891417-3FF1-411F-A1FE-D302F15D0B90Q38375202-CDECD544-7107-4C47-BD8F-ADC56C1ED2C1Q38563300-80250178-EDC5-4EEF-B480-A8BECC80C3BFQ38895037-3C513C5B-FA49-4D0B-BA9F-ACE4523C4489Q39185363-896EF341-6F5F-46AB-87EC-E77741B3F1EDQ39421460-AEED03D6-95C3-4A48-BF82-5D2B1123E913Q39629598-70E54696-A350-4E80-98B1-C25521352443Q39670210-3E4C4B7A-13BE-4A18-B1EF-DA8314A34605Q41010363-741019B9-7339-4564-9DFA-58FBBEEBE690Q41974579-8DEDFBA8-A3CC-44EF-B6FB-50DA251180EFQ45269063-3713DCF0-9255-42FD-B58F-BC1E718D08C4Q52564618-2F7C8352-FA76-4767-AA45-1EB6F3C1F77BQ55406267-42C56C14-A039-44F9-856D-8C1F990E93C7
P2860
Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@ast
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@en
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@nl
type
label
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@ast
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@en
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@nl
prefLabel
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@ast
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@en
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@nl
P2860
P356
P1476
Augmented synthesis and differ ...... in Duchenne muscular dystrophy
@en
P2093
Karin Alvarez
Ricardo Fadic
P2860
P304
P356
10.1002/JCB.10184
P407
P577
2002-01-01T00:00:00Z